Pulse Biosciences, Inc. Proceeds from Issuance of Private Placement
Pulse Biosciences, Inc. (PLSE) reported Proceeds from Issuance of Private Placement of $4.89 million for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-10.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfPrivatePlacement · last filed 2021-05-10
- Pulse Biosciences, Inc. proceeds from issuance of private placement for the quarter ending 2021-03-31 was $4.89M.
- Pulse Biosciences, Inc. proceeds from issuance of private placement for the quarter ending 2020-09-30 was -$261.00K.
- Pulse Biosciences, Inc. proceeds from issuance of private placement for the quarter ending 2017-03-31 was $4.96M.
- Pulse Biosciences, Inc. proceeds from issuance of private placement for fiscal 2017 was $34.84M.
| Period end | Proceeds from Issuance of Private Placement 3 month | Proceeds from Issuance of Private Placement 6 month | Proceeds from Issuance of Private Placement 7 month | Proceeds from Issuance of Private Placement 9 month | Proceeds from Issuance of Private Placement 12 month |
|---|---|---|---|---|---|
| 2021-03-31 | $4.89M 10-Q · filed 2021-05-10 | ||||
| 2020-09-30 | -$261.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $29.50M 10-Q · filed 2020-11-09 | |||
| 2020-06-30 | $29.76M 10-Q · filed 2020-08-10 | ||||
| 2017-12-31 | $34.84M 10-K · filed 2020-03-16 | ||||
| 2017-03-31 | $4.96M 10-Q · filed 2017-05-10 | ||||
| 2014-12-31 | $7.15M 10-K · filed 2017-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |